プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Christophe P.に依頼

United States

Scientific Program Leader | Preclinical Development & AI Model Evaluation | Translational Research

プロフィール概要

Accomplished scientific program leader with over 10 years of experience in molecular and cellular biology, now applying that expertise to AI model evaluation and development initiatives. Demonstrated ability to oversee complex, cross-functional projects, implement structured evaluation frameworks, and optimize workflows to enhance model performance and operational efficiency. Successfully managed large-scale, high-volume evaluation efforts, leveraging strong analytical skills to generate actionable insights and improve accuracy, reliability, and alignment of AI systems. Committed to delivering high-quality, data-driven outcomes that support strategic organizational goals.

専門分野

• ☆ Animal Science
• ☆ Animal Behavior/Ethology
• ☆ Animal Biotechnology
• ☆ Animal Breeding
• ☆ Animal Genetics
• ☆ Biochemical Assays
• ☆ Drug Development
• ☆ Preclinical Research
• ☆ Technical & Scientific Writing
• ☆ Project Management

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Non-Medical Regulatory Writing, Technical Writing, General Proofreading & Editing, Translation

Research Market Research, Scientific and Technical Research

Consulting Scientific and Technical Consulting

Data & AI Data Visualization

職務経験

STEM AI Content Specialist

Outlier, Handshake

2月 2024 - 現在

Scientist

Aragen Bioscience

7月 2019 - 7月 2024

Scientist

Stanford University

11月 2018 - 6月 2019

Scientist

BMS

10月 2017 - 10月 2018

Postdoc & research staff

Stanford University

9月 2014 - 10月 2017

Postdoc & instructor

Emory University

2月 2011 - 8月 2014

学歴

PhD

Laval University

8月 2005 - 12月 2010

認定資格

• Project Management Professional

  PMI

  5月 2026 - 12月 2026

出版物

JOURNAL ARTICLE

Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P., Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P.(2017). DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B . Molecular Therapy - Methods and Clinical Development. 7. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 123-131.

Pichavant, C., Burkholder, T.J., Pavlath, G.K.(2016). Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress . Skeletal Muscle. 6. (1).

Simionescu-Bankston, A., Pichavant, C., Canner, J.P., Apponi, L.H., Wang, Y., Steeds, C., Olthoff, J.T., Belanto, J.J., Ervasti, J.M., Pavlath, G.K.(2015). Creatine kinase B is necessary to limit myoblast fusion during myogenesis . American Journal of Physiology - Cell Physiology. 308. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString C919-C931.

Pichavant, C., Pavlath, G.K.(2014). Incidence and severity of myofiber branching with regeneration and aging . Skeletal Muscle. 4. (1).

Pichavant, C., Gargioli, C., Tremblay, J.P.(2011). Intramuscular transplantation of muscle precursor cells over-expressing MMP-9 improves transplantation success . PLoS Currents.

Pichavant, C., Aartsma-Rus, A., Clemens, P.R., Davies, K.E., Dickson, G., Takeda, S., Wilton, S.D., Wolff, J.A., Wooddell, C.I., Xiao, X., et al.(2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD . Molecular Therapy. 19. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 830-840.

Pichavant, C., Chapdelaine, P., Cerri, D.G., Dominique, J.-C., Quenneville, S.P., Skuk, D., Kornegay, J.N., Bizario, J.C., Xiao, X., Tremblay, J.P.(2010). Expression of dog microdystrophin in mouse and dog muscles by gene therapy . Molecular Therapy. 18. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1002-1009.

Pichavant, C., Chapdelaine, P., Cerri, D.G., Bizario, J.C.S., Tremblay, J.P.(2010). Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles . Human Gene Therapy. 21. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1591-1601.

Chapdelaine, P., Pichavant, C., Rousseau, J., Pâques, F., Tremblay, J.P.(2010). Meganucleases can restore the reading frame of a mutated dystrophin . Gene Therapy. 17. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 846-858.

Stephan, L., Pichavant, C., Bouchentouf, M., Mills, P., Camirand, G., Tagmouti, S., Rothstein, D., Tremblay, J.P.(2006). Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use . Cell Transplantation. 15. (8-9). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 835-846.

BOOK

Pichavant, C., Tremblay, J.P.(2012). Generation of lentiviral vectors for use in skeletal muscle research . Methods in Molecular Biology. 798. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 285-295.